Gut Bacteria Contribute to Improved Prediction of Type 2 Diabetes

July 08, 2020

Type 2 diabetes risk prediction is improved by observing changes in gut bacteria, a study finds.

Ready-to-Use Glucagon Injection for Severe Hypoglycemia Now Available

July 06, 2020

Xeris Pharmaceuticals’ new glucagon injection (Gvoke HypoPen), a ready-to-use glucagon formulation in a premixed autoinjector, is now available by prescription.

Risk of Death By Heart Failure Increases With Recent Diagnosis of Type 2 Diabetes

July 02, 2020

Individuals recently diagnosed with type 2 diabetes were more likely to die from heart failure than any other cardiovascular disease, a study found.

CDC: Partnerships With Pharmacists Expand Diabetes Prevention Efforts

July 01, 2020

The CDC has identified the pharmacy sector as a key partner in offering its lifestyle change-based program for patients with high risk for type 2 diabetes.

FDA Approves Treatment for Recurrent Diabetes Gastroparesis

June 23, 2020

The first and only one of its kind, metoclopramide nasal spray offers relief to often debilitating symptoms of the gastrointestinal disease.

NYC-Based Study Improves A1c Levels in Poverty Areas With High Diabetes Prevalence

June 19, 2020

In response to the study, the NYC Department of Health is pursuing large-scale implementation of this approach, targeting diabetes hot spots across the city through public health messaging, mailed print materials, and Care Calls.

Addressing Diabetes Management Disparities in Minority Children

June 18, 2020

“We know that if we don’t address these potential difficulties before they occur, the burden to families can be devastating and the health care costs are tremendous.”

ADA2020: A Look at Digital Diabetes Self-Management Support Programs

June 18, 2020

A study presented at the American Diabetes Association 80th Annual Scientific Sessions examined the impact of digital Diabetes Self-Management Support systems.

FDA OKs FreeStyle Libre 2 System for Adults and Children With Diabetes

June 15, 2020

Abbott’s FreeStyle Libre 2 is an integrated continuous glucose monitoring system for adults and children ages 4 and older with diabetes.

Study Gauges Attitudes Toward Glucagon Delivery Devices for Rescue Treatment of Severe Hypoglycemia

June 15, 2020

A study presented during the American Diabetes Association 80th Scientific Sessions focused on assessing preference and attitudes from patients with diabetes, their caregivers, and acquaintances.